Patient Engagement Solutions Market (By Delivery Type: Web & Cloud-based, On-premise; By Component: Software & Hardware, Services; By Functionality: Communication, Health Tracking & Insights, Billing & Payments, Administrative, Patient Education; By Therapeutic Area: Health & Wellness, Chronic Disease Management; By Application: Population Health Management, Outpatient Health Management, In-patient Health Management; By End-use - Payers, Providers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20222030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Patient Engagement Solutions Market, By Delivery Type

7.1.  Patient Engagement Solutions Market, by Delivery Type, 2021-2030

7.1.1.    Web & Cloud-based

7.1.1.1.        Market Revenue and Forecast (2019-2030)

7.1.2.    On-premise

7.1.2.1.        Market Revenue and Forecast (2019-2030)

Chapter 8.  Global Patient Engagement Solutions Market, By Application

8.1.  Patient Engagement Solutions Market, by Application, 2021-2030

8.1.1.    Software & Hardware

8.1.1.1.        Market Revenue and Forecast (2019-2030)

8.1.2.    Services

8.1.2.1.        Market Revenue and Forecast (2019-2030)

Chapter 9.  Global Patient Engagement Solutions Market, By Functionality

9.1.  Patient Engagement Solutions Market, by Functionality, 2021-2030

9.1.1.    Communication

9.1.1.1.        Market Revenue and Forecast (2019-2030)

9.1.2.    Health Tracking & Insights

9.1.2.1.        Market Revenue and Forecast (2019-2030)

9.1.3.    Billing & Payments

9.1.3.1.        Market Revenue and Forecast (2019-2030)

9.1.4.    Administrative

9.1.4.1.        Market Revenue and Forecast (2019-2030)

9.1.5.    Patient Education

9.1.5.1.        Market Revenue and Forecast (2019-2030)

Chapter 10.      Global Patient Engagement Solutions Market, By Therapeutic Area

10.1.        Patient Engagement Solutions Market, by Therapeutic Area, 2021-2030

10.1.1.  Health & Wellness

10.1.1.1.      Market Revenue and Forecast (2019-2030)

10.1.2.  Chronic Disease Management

10.1.2.1.      Market Revenue and Forecast (2019-2030)

Chapter 11.      Global Patient Engagement Solutions Market, By Application

11.1.        Patient Engagement Solutions Market, by Application, 2021-2030

11.1.1.  Population Health Management

11.1.1.1.      Market Revenue and Forecast (2019-2030)

11.1.2.  Outpatient Health Management

11.1.2.1.      Market Revenue and Forecast (2019-2030)

11.1.3.  In-patient Health Management

11.1.3.1.      Market Revenue and Forecast (2019-2030)

Chapter 12.      Global Patient Engagement Solutions Market, By End-user

12.1.        Patient Engagement Solutions Market, by End-user, 2021-2030

12.1.1.  Payers

12.1.1.1.      Market Revenue and Forecast (2019-2030)

12.1.2.  Providers

12.1.2.1.      Market Revenue and Forecast (2019-2030)

Chapter 13.      Global Patient Engagement Solutions  Market, Regional Estimates and Trend Forecast

13.1.        North America

13.1.1.  Market Revenue and Forecast, by Delivery Type (2019-2030)

13.1.2.  Market Revenue and Forecast, by Application (2019-2030)

13.1.3.  Market Revenue and Forecast, by Functionality (2019-2030)

13.1.4.  Market Revenue and Forecast, by Therapeutic Area (2019-2030)

13.1.5.  Market Revenue and Forecast, by Application (2019-2030)

13.1.6.  Market Revenue and Forecast, by End-user (2019-2030)

13.1.7.  U.S.

13.1.7.1.      Market Revenue and Forecast, by Delivery Type (2019-2030)

13.1.7.2.      Market Revenue and Forecast, by Application (2019-2030)

13.1.7.3.      Market Revenue and Forecast, by Functionality (2019-2030)

13.1.7.4.      Market Revenue and Forecast, by Therapeutic Area (2019-2030)

13.1.7.5.      Market Revenue and Forecast, by Application (2019-2030)

13.1.7.6.      Market Revenue and Forecast, by End-user (2019-2030)

13.1.8.  Rest of North America

13.1.8.1.      Market Revenue and Forecast, by Delivery Type (2019-2030)

13.1.8.2.      Market Revenue and Forecast, by Application (2019-2030)

13.1.8.3.      Market Revenue and Forecast, by Functionality (2019-2030)

13.1.8.4.      Market Revenue and Forecast, by Therapeutic Area (2019-2030)

13.1.8.5.      Market Revenue and Forecast, by Application (2019-2030)

13.1.8.6.      Market Revenue and Forecast, by End-user (2019-2030)

13.2.        Europe

13.2.1.  Market Revenue and Forecast, by Delivery Type (2019-2030)

13.2.2.  Market Revenue and Forecast, by Application (2019-2030)

13.2.3.  Market Revenue and Forecast, by Functionality (2019-2030)

13.2.4.  Market Revenue and Forecast, by Therapeutic Area (2019-2030)

13.2.5.  Market Revenue and Forecast, by Application (2019-2030)

13.2.6.  Market Revenue and Forecast, by End-user (2019-2030)

13.2.7.  UK

13.2.7.1.      Market Revenue and Forecast, by Delivery Type (2019-2030)

13.2.7.2.      Market Revenue and Forecast, by Application (2019-2030)

13.2.7.3.      Market Revenue and Forecast, by Functionality (2019-2030)

13.2.7.4.      Market Revenue and Forecast, by Therapeutic Area (2019-2030)

13.2.7.5.      Market Revenue and Forecast, by Application (2019-2030)

13.2.7.6.      Market Revenue and Forecast, by End-user (2019-2030)

13.2.8.  Germany

13.2.8.1.      Market Revenue and Forecast, by Delivery Type (2019-2030)

13.2.8.2.      Market Revenue and Forecast, by Application (2019-2030)

13.2.8.3.      Market Revenue and Forecast, by Functionality (2019-2030)

13.2.8.4.      Market Revenue and Forecast, by Therapeutic Area (2019-2030)

13.2.8.5.      Market Revenue and Forecast, by Application (2019-2030)

13.2.8.6.      Market Revenue and Forecast, by End-user (2019-2030)

13.2.9.  France

13.2.9.1.      Market Revenue and Forecast, by Delivery Type (2019-2030)

13.2.9.2.      Market Revenue and Forecast, by Application (2019-2030)

13.2.9.3.      Market Revenue and Forecast, by Functionality (2019-2030)

13.2.9.4.      Market Revenue and Forecast, by Therapeutic Area (2019-2030)

13.2.9.5.      Market Revenue and Forecast, by Application (2019-2030)

13.2.9.6.      Market Revenue and Forecast, by End-user (2019-2030)

13.2.10.               Rest of Europe

13.2.10.1.   Market Revenue and Forecast, by Delivery Type (2019-2030)

13.2.10.2.   Market Revenue and Forecast, by Application (2019-2030)

13.2.10.3.   Market Revenue and Forecast, by Functionality (2019-2030)

13.2.10.4.   Market Revenue and Forecast, by Therapeutic Area (2019-2030)

13.2.10.5.   Market Revenue and Forecast, by Application (2019-2030)

13.2.10.6.   Market Revenue and Forecast, by End-user (2019-2030)

13.3.        APAC

13.3.1.  Market Revenue and Forecast, by Delivery Type (2019-2030)

13.3.2.  Market Revenue and Forecast, by Application (2019-2030)

13.3.3.  Market Revenue and Forecast, by Functionality (2019-2030)

13.3.4.  Market Revenue and Forecast, by Therapeutic Area (2019-2030)

13.3.5.  Market Revenue and Forecast, by Application (2019-2030)

13.3.6.  Market Revenue and Forecast, by End-user (2019-2030)

13.3.7.  India

13.3.7.1.      Market Revenue and Forecast, by Delivery Type (2019-2030)

13.3.7.2.      Market Revenue and Forecast, by Application (2019-2030)

13.3.7.3.      Market Revenue and Forecast, by Functionality (2019-2030)

13.3.7.4.      Market Revenue and Forecast, by Therapeutic Area (2019-2030)

13.3.7.5.      Market Revenue and Forecast, by Application (2019-2030)

13.3.7.6.      Market Revenue and Forecast, by End-user (2019-2030)

13.3.8.  China

13.3.8.1.      Market Revenue and Forecast, by Delivery Type (2019-2030)

13.3.8.2.      Market Revenue and Forecast, by Application (2019-2030)

13.3.8.3.      Market Revenue and Forecast, by Functionality (2019-2030)

13.3.8.4.      Market Revenue and Forecast, by Therapeutic Area (2019-2030)

13.3.8.5.      Market Revenue and Forecast, by Application (2019-2030)

13.3.8.6.      Market Revenue and Forecast, by End-user (2019-2030)

13.3.9.  Japan

13.3.9.1.      Market Revenue and Forecast, by Delivery Type (2019-2030)

13.3.9.2.      Market Revenue and Forecast, by Application (2019-2030)

13.3.9.3.      Market Revenue and Forecast, by Functionality (2019-2030)

13.3.9.4.      Market Revenue and Forecast, by Therapeutic Area (2019-2030)

13.3.9.5.      Market Revenue and Forecast, by Application (2019-2030)

13.3.9.6.      Market Revenue and Forecast, by End-user (2019-2030)

13.3.10.               Rest of APAC

13.3.10.1.   Market Revenue and Forecast, by Delivery Type (2019-2030)

13.3.10.2.   Market Revenue and Forecast, by Application (2019-2030)

13.3.10.3.   Market Revenue and Forecast, by Functionality (2019-2030)

13.3.10.4.   Market Revenue and Forecast, by Therapeutic Area (2019-2030)

13.3.10.5.   Market Revenue and Forecast, by Application (2019-2030)

13.3.10.6.   Market Revenue and Forecast, by End-user (2019-2030)

13.4.        MEA

13.4.1.  Market Revenue and Forecast, by Delivery Type (2019-2030)

13.4.2.  Market Revenue and Forecast, by Application (2019-2030)

13.4.3.  Market Revenue and Forecast, by Functionality (2019-2030)

13.4.4.  Market Revenue and Forecast, by Therapeutic Area (2019-2030)

13.4.5.  Market Revenue and Forecast, by Application (2019-2030)

13.4.6.  Market Revenue and Forecast, by End-user (2019-2030)

13.4.7.  GCC

13.4.7.1.      Market Revenue and Forecast, by Delivery Type (2019-2030)

13.4.7.2.      Market Revenue and Forecast, by Application (2019-2030)

13.4.7.3.      Market Revenue and Forecast, by Functionality (2019-2030)

13.4.7.4.      Market Revenue and Forecast, by Therapeutic Area (2019-2030)

13.4.7.5.      Market Revenue and Forecast, by Application (2019-2030)

13.4.7.6.      Market Revenue and Forecast, by End-user (2019-2030)

13.4.8.  North Africa

13.4.8.1.      Market Revenue and Forecast, by Delivery Type (2019-2030)

13.4.8.2.      Market Revenue and Forecast, by Application (2019-2030)

13.4.8.3.      Market Revenue and Forecast, by Functionality (2019-2030)

13.4.8.4.      Market Revenue and Forecast, by Therapeutic Area (2019-2030)

13.4.8.5.      Market Revenue and Forecast, by Application (2019-2030)

13.4.8.6.      Market Revenue and Forecast, by End-user (2019-2030)

13.4.9.  South Africa

13.4.9.1.      Market Revenue and Forecast, by Delivery Type (2019-2030)

13.4.9.2.      Market Revenue and Forecast, by Application (2019-2030)

13.4.9.3.      Market Revenue and Forecast, by Functionality (2019-2030)

13.4.9.4.      Market Revenue and Forecast, by Therapeutic Area (2019-2030)

13.4.9.5.      Market Revenue and Forecast, by Application (2019-2030)

13.4.9.6.      Market Revenue and Forecast, by End-user (2019-2030)

13.4.10.               Rest of MEA

13.4.10.1.   Market Revenue and Forecast, by Delivery Type (2019-2030)

13.4.10.2.   Market Revenue and Forecast, by Application (2019-2030)

13.4.10.3.   Market Revenue and Forecast, by Functionality (2019-2030)

13.4.10.4.   Market Revenue and Forecast, by Therapeutic Area (2019-2030)

13.4.10.5.   Market Revenue and Forecast, by Application (2019-2030)

13.4.10.6.   Market Revenue and Forecast, by End-user (2019-2030)

13.5.        Latin America

13.5.1.  Market Revenue and Forecast, by Delivery Type (2019-2030)

13.5.2.  Market Revenue and Forecast, by Application (2019-2030)

13.5.3.  Market Revenue and Forecast, by Functionality (2019-2030)

13.5.4.  Market Revenue and Forecast, by Therapeutic Area (2019-2030)

13.5.5.  Market Revenue and Forecast, by Application (2019-2030)

13.5.6.  Market Revenue and Forecast, by End-user (2019-2030)

13.5.7.  Brazil

13.5.7.1.      Market Revenue and Forecast, by Delivery Type (2019-2030)

13.5.7.2.      Market Revenue and Forecast, by Application (2019-2030)

13.5.7.3.      Market Revenue and Forecast, by Functionality (2019-2030)

13.5.7.4.      Market Revenue and Forecast, by Therapeutic Area (2019-2030)

13.5.7.5.      Market Revenue and Forecast, by Application (2019-2030)

13.5.7.6.      Market Revenue and Forecast, by End-user (2019-2030)

13.5.8.  Rest of LATAM

13.5.8.1.      Market Revenue and Forecast, by Delivery Type (2019-2030)

13.5.8.2.      Market Revenue and Forecast, by Application (2019-2030)

13.5.8.3.      Market Revenue and Forecast, by Functionality (2019-2030)

13.5.8.4.      Market Revenue and Forecast, by Therapeutic Area (2019-2030)

13.5.8.5.      Market Revenue and Forecast, by Application (2019-2030)

13.5.8.6.      Market Revenue and Forecast, by End-user (2019-2030)

Chapter 14.  Company Profiles

14.1.              Cerner Corporation (Oracle)

14.1.1.  Company Overview

14.1.2.  Product Offerings

14.1.3.  Financial Performance

14.1.4.  Recent Initiatives

14.2.              NextGen Healthcare, Inc.

14.2.1.  Company Overview

14.2.2.  Product Offerings

14.2.3.  Financial Performance

14.2.4.  Recent Initiatives

14.3.              Epic Systems Corporation

14.3.1.  Company Overview

14.3.2.  Product Offerings

14.3.3.  Financial Performance

14.3.4.  Recent Initiatives

14.4.              Allscripts Healthcare, LLC

14.4.1.  Company Overview

14.4.2.  Product Offerings

14.4.3.  Financial Performance

14.4.4.  Recent Initiatives

14.5.              McKesson Corporation

14.5.1.  Company Overview

14.5.2.  Product Offerings

14.5.3.  Financial Performance

14.5.4.  Recent Initiatives

14.6.              ResMed

14.6.1.  Company Overview

14.6.2.  Product Offerings

14.6.3.  Financial Performance

14.6.4.  Recent Initiatives

14.7.              Koninklijke Philips N.V.

14.7.1.  Company Overview

14.7.2.  Product Offerings

14.7.3.  Financial Performance

14.7.4.  Recent Initiatives

14.8.              Klara Technologies, Inc.

14.8.1.  Company Overview

14.8.2.  Product Offerings

14.8.3.  Financial Performance

14.8.4.  Recent Initiatives

14.9.              CPSI

14.9.1.  Company Overview

14.9.2.  Product Offerings

14.9.3.  Financial Performance

14.9.4.  Recent Initiatives

14.10.           Experian Information Solutions, Inc.

14.10.1.               Company Overview

14.10.2.               Product Offerings

14.10.3.               Financial Performance

14.10.4.               Recent Initiatives

Chapter 15.  Research Methodology

15.1.              Primary Research

15.2.              Secondary Research

15.3.              Assumptions

Chapter 16.  Appendix

16.1.              About Us

16.2.              Glossary of Terms